Shares of DaVita Inc. (DVA) moved sharply higher on Wednesday, extending recent gains after the kidney-care provider reported better-than-expected fourth-quarter and full-year 2025 results on Tuesday, along with upbeat guidance for 2026.
The stock is currently trading at $144.95, up $10.04 or 7.44%, on the NYSE. The stock opened at $136.06 after closing Tuesday at $134.91. The stock has traded between $101.00 and $178.47 in the past 52-week period.
Investors continued to respond positively to DaVita's results, which topped Wall Street expectations and pointed to continued earnings momentum in 2026.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.